Fundz

Medtech startup Bioscan Research raises $1 million in seed round led by Unicorn India Ventures to expand market reach and enhance product offerings.

PRIVATEJul 22, 2026

Amount Raised

$1 Million

Round Type

Seed

MumbaiBiotechnologyHealth CareMedical DeviceHealth Diagnostics

Investors

Unicorn India Ventures

Description

Mumbai-based medtech startup Bioscan Research has raised $1 million in a seed funding round led by Unicorn India Ventures. The proceeds will be used for market expansion, securing additional regulatory approvals, upgrading its products, and creating new intellectual property. Founded in 2017, Bioscan Research develops non-invasive medical devices for early detection of brain injuries. The company aims to grow threefold over the next year by expanding its presence in India and overseas markets.

Quick answer

Bioscan Research raised $1 Million in a Seed round, dated July 22, 2026. Investors: Unicorn India Ventures. Bioscan Research is based in Mumbai, Maharashtra, India.

How much did Bioscan Research raise?
Bioscan Research raised $1 Million in a Seed round on July 22, 2026.
Who invested in Bioscan Research?
Unicorn India Ventures is named as investors in this round.
What does Bioscan Research do?
Bioscan Research is a medtech startup that develops non-invasive medical devices for early detection of brain injuries.
Where is Bioscan Research based and how big is it?
Bioscan Research is based in Mumbai, Maharashtra, India.

Source: Fundz verified event record.

Who else raised in Medical Device and Health Diagnostics around the same time

Companies in the same sectors as Bioscan Research that raised within 45 days of this round, from Fundz verified event records.

  • MiMARK Diagnostics raised $4.9M (Seed) on August 26, 2026.
  • Ayati Devices raised $1.6M (Pre-Series A) on August 11, 2026.
  • Vexev raised $6M on August 6, 2026.
  • Mediqstar raised an undisclosed amount (Series B) on August 3, 2026.
  • TidalSense raised $19M on July 24, 2026.
  • Neuble AI raised $269K (Seed) on July 16, 2026.

Who to call at Bioscan Research, and when

A new round usually means Bioscan Research is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Bioscan Research raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Bioscan Research, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Bioscan Research. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Bioscan Research

Location

Mumbai, Maharashtra, India

About

Bioscan Research is a medtech startup that develops non-invasive medical devices for early detection of brain injuries. Its flagship product, CEREBO, utilizes near-infrared spectroscopy (NIRS) and machine learning for detecting intracranial injuries. Founded in 2017 by Anupam Lavania and Shilpa Malik, the company aims to improve patient outcomes by identifying brain injuries during critical treatment windows.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Bioscan Research raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Bioscan Research's next move

See what Strategic adds

Bioscan Research raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.